Pharmacokinetics of haloperidol decanoate. A 2-year follow-up. 1982

A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts

Plasma haloperidol levels were assayed in 181 chronic schizophrenic inpatients, who were monthly injected intramuscularly with haloperidol decanoate. Steady state levels are reached after the third monthly injection and then remain constant, being associated with a remarkably stable control of the psychotic condition. Between two subsequent injections the haloperidol levels decrease gradually by about half their initial value. The haloperidol plasma levels strongly correlate with the injected doses of the decanoate form. For a single dose of 100 mg haloperidol decanoate monthly the minimal steady state value is about 4 ng/ml.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
January 1991, Clinical neuropharmacology,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
November 1991, Journal of pharmacobio-dynamics,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
July 1986, International clinical psychopharmacology,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
September 1989, The Australian and New Zealand journal of psychiatry,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
April 1992, Journal of clinical psychopharmacology,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
January 1984, Pharmatherapeutica,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
May 1986, The British journal of psychiatry : the journal of mental science,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
January 1987, L'Encephale,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
April 1988, Drug intelligence & clinical pharmacy,
A J Reyntigens, and J J Heykants, and R J Woestenborghs, and Y G Gelders, and T J Aerts
May 1983, Drug and therapeutics bulletin,
Copied contents to your clipboard!